Skip to main content

MECANISMOS REGULADORES Y FUNCION DE LAS FOSFATASAS DE REGENERACION HEPATICA Y ‘SLINGSHOTS’ DURANTE LAS RESPUESTAS INMUNITARIAS

PID2020-115444GB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSIDAD COMPLUTENSE DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

Docta Complutense
Publication Artículo científico (JournalArticle)

Human T-cell receptor triggering requires inactivation of Lim kinase-1 by Slingshot-1 phosphatase.

  • Gómez-Morón, Álvaro
  • Alegre Gómez, Sergio
  • Ramírez Muñoz, Rocío
  • Hernaiz-Esteban, Alicia
  • Carrasco-Padilla, Carlos
  • Scagnetti, Camila
  • Aguilar-Sopeña, Óscar
  • García-Gil, Marta
  • Borroto, Aldo
  • Torres-Ruiz, Raul
  • Rodríguez Perales, Sandra
  • Sánchez-Madrid, Francisco
  • Martín-Cófreces, Noa Beatriz
  • Roda Navarro, Pedro
Actin dynamics control early T-cell receptor (TCR) signalling during T-cell activation. However, the precise regulation of initial actin rearrangements is not completely understood. Here, we have investigated the regulatory role of the phosphatase Slingshot-1 (SSH1) in this process. Our data show that SSH1 rapidly polarises to nascent cognate synaptic contacts and later relocalises to peripheral F-actin networks organised at the mature immunological synapse. Knockdown of SSH1 expression by CRISPR/Cas9-mediated genome editing or small interfering RNA reveal a regulatory role for SSH1 in CD3ε conformational change, allowing Nck binding and proper downstream signalling and immunological synapse organisation. TCR triggering induces SSH1-mediated activation of actin dynamics through a mechanism mediated by Limk-1 inactivation. These data suggest that during early TCR activation, SSH1 is required for rapid F-actin rearrangements that mediate initial conformational changes of the TCR, integrin organisation and proximal signalling events for proper synapse organisation. Therefore, the SSH1 and Limk-1 axis is a key regulatory element for full T cell activation.
Docta Complutense
Publication Artículo científico (JournalArticle)

Synapse topology and downmodulation events determine the functional outcome of anti-CD19 T cell-redirecting strategies

  • Ramírez Fernández, Ángel
  • Aguilar Sopeña, Óscar
  • Díez Alonso, Laura
  • Segura Tudela, Alejandro
  • Domínguez Alonso, Carmen
  • Roda Navarro, Pedro
  • Álvarez Vallina, Luis
  • Blanco, Belén
Cancer immunotherapy strategies based on the endogenous secretion of T cell-redirecting bispecific antibodies by engineered T lymphocytes (STAb-T) are emerging as alternative or complementary approaches to those based on chimeric antigen receptors (CAR-T). The antitumor efficacy of bispecific anti-CD19 × anti-CD3 (CD19×CD3) T cell engager (BiTE)-secreting STAb-T cells has been demonstrated in several mouse models of B-cell acute leukemia. Here, we have investigated the spatial topology and downstream signaling of the artificial immunological synapses (IS) that are formed by CAR-T or STAb-T cells. Upon interaction with CD19-positive target cells, STAb-T cells form IS with structure and signal transduction, which more closely resemble those of physiological cognate IS, compared to IS formed by CAR-T cells expressing a second-generation CAR bearing the same CD19-single-chain variable fragment. Importantly, while CD3 is maintained at detectable levels on the surface of STAb-T cells, indicating sustained activation mediated by the secreted BiTE, the anti-CD19 CAR was rapidly downmodulated, which correlated with a more transient downstream signaling. Furthermore, CAR-T cells, but not STAb-T cells, provoke an acute loss of CD19 in target cells. Such differences might represent advantages of the STAb-T strategy over the CAR-T approach and should be carefully considered in order to develop more effective and safer treatments for hematological malignancies.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mechanical stress confers nuclear and functional changes in derived leukemia cells from persistent confined migration

  • De Lope Planelles, A.
  • González-Novo, Raquel
  • Madrazo, Elena
  • Peralta-Carrero, Gracia
  • Cruz Rodríguez, María Pilar
  • Zamora-Carreras, H.
  • Torrano, Verónica
  • López-Menéndez, Horacio
  • Roda-Navarro, Pedro
  • Monroy, Francisco
  • Redondo-Muñoz, Javier
20 p.-8 fig., Nuclear deformability plays a critical role in cell migration. During this process, the remodeling of internal components of the nucleus has a direct impact on DNA damage and cell behavior; however, how persistent migration promotes nuclear changes leading to phenotypical and functional consequences remains poorly understood. Here, we described that the persistent migration through physical barriers was sufficient to promote permanent modifications in migratory-altered cells. We found that derived cells from confined migration showed changes in lamin B1 localization, cell morphology and transcription. Further analysis confirmed that migratory-altered cells showed functional differences in DNA repair, cell response to chemotherapy and cell migration in vivo homing experiments. Experimental modulation of actin polymerization affected the redistribution of lamin B1, and the basal levels of DNA damage in migratory-altered cells. Finally, since major nuclear changes were present in migratory-altered cells, we applied a multidisciplinary biochemical and biophysical approach to identify that confined conditions promoted a different biomechanical response of the nucleus in migratory-altered cells. Our observations suggest that mechanical compression during persistent cell migration has a role in stable nuclear and genomic alterations that might handle the genetic instability and cellular heterogeneity in aging diseases and cancer., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This research was supported by a FPI Scholarship 2018 (Ministerio de Ciencia e Innovación/MICINN, Agencia Estatal de Investigación/AEI y Fondo Europeo de Desarrollo Regional/FEDER) to R.G.N.; JAE Intro 2022 (Agencia Estatal Consejo Superior de Investigaciones Científicas, Conexión CSIC Cancer, JAE-ICU-CC-34 and JAEINT22_EX_0263) to G.P.C. and M.P.C.R; grants from the Ministerio de Ciencia e Innovación (MICINN) Agencia Estatal de Investigación (AEI) (RTI2018-097267-B-I00), Asociación Española Contra el Cáncer (LAB AECC, LABAE211656TORR) and Beca FERO (BFERO2021.01) to V.T.; Comunidad de Madrid (Y2018/BIO-5207) and from the Ministerio de Ciencia e Innovación (MICINN) Agencia Estatal de Investigación (AEI) (PID2020-115444 GB-I00) to P.R.N; grants from the Ministerio de Ciencia e Innovación (MICINN) Agencia Estatal de Investigación (AEI) (TED2021-132296B-C52, PID2019-108391RB-100), and Comunidad de Madrid (Y2018/BIO-5207, S2018/NMT-4389 and REACT-EU program PR38-21–28 ANTICIPA-CM) to F.M.; and grants from 2020 Leonardo Grant for Researchers and Cultural Creators (BBVA Foundation), Ayuda de contratación de ayudante de investigación PEJ-2020-AI/BMD-19152 (Comunidad de Madrid), Comunidad de Madrid (Y2018/BIO-5207) and the Ministerio de Ciencia e Innovación (MICINN) Agencia Estatal de Investigación (AEI) (PID2020-118525RBI00, AEI/10.13039/501100011033) to J.R.M., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Engineered T cells secreting anti-BCMA T cell engagers control multiple myeloma and promote immune memory in vivo

  • Díez-Alonso, Laura
  • Falgàs, Aïda
  • Arroyo-Ródenas, Javier
  • Romencín, Paola A
  • Martínez, Alba
  • Gómez-Rosel, Marina
  • Blanco, Belén
  • Jiménez-Reinoso, Anaïs
  • Mayado, Andrea
  • Pérez-Pons, Alba
  • Aguilar-Sopeña, Óscar
  • Ramírez-Fernández, Ángel
  • Segura-Tudela, Alejandro
  • Perez-Amill, Lorena
  • Tapia-Galisteo, Antonio
  • Domínguez-Alonso, Carmen
  • Rubio-Pérez, Laura
  • Jara-Acevedo, Maria
  • Solé, Francesc
  • Hangiu, Oana
  • Almagro, Laura
  • Albitre, Ángela
  • Penela, Petronila
  • Sanz, Laura
  • Anguita, Eduardo
  • Valeri, Antonio
  • García-Ortiz, Almudena
  • Río, Paula
  • Juan, Manel
  • Martínez-López, Joaquín
  • Roda-Navarro, Pedro
  • Martin-Antonio, Beatriz
  • Orfao, Alberto
  • Menéndez, Pablo
  • Bueno, Clara
  • Álvarez-Vallina, Luis
Multiple myeloma is the second most common hematological malignancy in adults and remains an incurable disease. B cell maturation antigen (BCMA)–directed immunotherapy, including T cells bearing chimeric antigen receptors (CARs) and systemically injected bispecific T cell engagers (TCEs), has shown remarkable clinical activity, and several products have received market approval. However, despite promising results, most patients eventually become refractory and relapse, highlighting the need for alternative strategies. Engineered T cells secreting TCE antibodies (STAb) represent a promising strategy that combines the advantages of adoptive cell therapies and bispecific antibodies. Here, we undertook a comprehensive preclinical study comparing the therapeutic potential of T cells either expressing second-generation anti-BCMA CARs (CAR-T) or secreting BCMAxCD3 TCEs (STAb-T) in a T cell–limiting experimental setting mimicking the conditions found in patients with relapsed/refractory multiple myeloma. STAb-T cells recruited T cell activity at extremely low effector-to-target ratios and were resistant to inhibition mediated by soluble BCMA released from the cell surface, resulting in enhanced cytotoxic responses and prevention of immune escape of multiple myeloma cells in vitro. These advantages led to robust expansion and persistence of STAb-T cells in vivo, generating long-lived memory BCMA-specific responses that could control multiple myeloma progression in xenograft models, outperforming traditional CAR-T cells. These promising preclinical results encourage clinical testing of the BCMA-STAb-T cell approach in relapsed/refractory multiple myeloma., Financial support for this work was obtained from the Spanish Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033 (PID2020-115444GB-I00 to P.R.-N., PID2019-108160RB-I00 to P.M., PLE2021-0075 to C.B., and PID2020-117323RB-100 and PDC2021-121711-100 to L.Á.-V.), partially supported by the European Regional Development Fund (ERDF); the Carlos III Health Institute (ISCIII) (PI20/01030 to B.B., PI19/00132 to L.S., PI21-01834 to P.P., PI20/00822 to C.B., and DTS20/00089 to L.Á.-V.), partially supported by the ERDF; the ISCIII-RICORS within the Next Generation EU program (plan de Recuperación, Transformación y Resilencia) (RD21/0017/0030 to B.B. and J.M.-L. and RD21/0017/0029 to P.M.); the ISCIII-CIBERONC program (CB16/12/00400 to A.O.), the CRIS Cancer Foundation (FCRIS-2021-001 to J.M.-L. and FCRIS-2021-0090 to L.Á.-V.), the Spanish Association Against Cancer (AECC) (PRYGN234975MENE to P.M., PRYGN211192BUEN to C.B., and PROYE19084ALVA and PRYGN234844ALVA to L.Á.-V.); the Accelerator Award-Cancer Research UK/AIRC/AECC-INCAR (GEACC18001ORF to A.O.), the Fundación “La Caixa” (LCF/PR/HR19/52160011 to P.M. and HR21-00761 project IL7R_LungCan to L.Á.-V.), the European Research Council (ERC) (ERC-PoC-957466 to P.M.) and ERC under the EU’s Horizon Program (grant agreement 101100665 to P.M.), the Fundación de Investigación Biomédica 12 de Octubre (programa Investiga 2022-0082) to L.Á.-V.; the Fundación Ramón Areces to P.P. L.D.-A. was supported by a Rio Hortega fellowship from the Carlos III Health Institute (CM20/00004). A.F. was supported by a postdoctoral fellowship from the Spanish Ministry of Science and Innovation (FJC2021-046789-I). A. Mayado was supported by the CIBERONC (PRF-2869). A.P.-P. was supported by a grant from the Government of Castilla y León (Orden EDU/556/2019; Valladolid, Spain). M.G.-R. was supported by an industrial PhD fellowship from the Comunidad de Madrid (IND2022/BMD-23732). O.A.-S. was supported by a PhD fellowship from the Complutense University of Madrid. C.D.-A. was supported by a PhD fellowship from the Spanish Ministry of Science and Innovation (PRE2018-083445). L.R.-P. was supported by a PhD fellowship from the Immunology Chair, Universidad Francisco de Vitoria/Merck. O.H. was supported by an industrial PhD fellowship from the Comunidad de Madrid (IND2020/BMD-17668). A.V. is supported by Research Institute Hospital 12 de Octubre (imas12). A.G.-O. is supported by HIGEA 2019/0123 AIE project to J.M.-L., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

3D environment promotes persistent changes in lamin B1 distribution, the biomechanical signature of the nucleus, and adaptative survival and migratory functions

  • González-Novo, Raquel
  • Zamora-Carreras, H.
  • De Lope Planelles, A.
  • López-Menéndez, Horacio
  • Roda-Navarro, Pedro
  • Monroy, Francisco
  • Wang, Lin
  • Toseland, Christopher P.
  • Redondo-Muñoz, Javier
32 p.-8 fig., The interplay between cells and their surrounding microenvironment drives multiple cellular functions, including migration, proliferation, and cell fate transitions. The nucleus is a mechanosensitive organelle that adapts external mechanical and biochemical signals provided by the environment into nuclear changes with functional consequences for cell biology. However, the morphological and functional changes of the nucleus induced by 3D extracellular signals remain unclear. Here, we demonstrated that cells derived from 3D conditions conserve changes from cell confinement and show an aberrant nuclear morphology and localization of lamin B1, even in the absence of cellular confinement. We found that actin polymerization and protein kinase C (PKC) activity mediate the abnormal distribution of lamin B1 in 3D conditions-derived cells. These cells present altered chromatin compaction, gene transcription and cellular functions such as cell viability and migration. By combining biomechanical techniques and single-nucleus analysis, we have determined that the nucleus from 3D conditions-derived cells shows a different mechanical behavior and biophysical signature than the nucleus from control cells. Together, our work substantiates novel insights into how the extracellular environment alters the cell biology by promoting permanent changes in the chromatin, morphology, lamin B1 distribution, and the mechanical response of the nucleus., This research was supported by a FPI Scholarship 2018 (Ministerio de Ciencia e Innovación/MICINN, Agencia Estatal de Investigación/AEI y Fondo Europeo de Desarrollo Regional/FEDER) to R.G.N.; grants from Comunidad de Madrid (Y2018/BIO-5207) and from the Ministerio de Ciencia e Innovación (MICINN) Agencia Estatal de Investigación (AEI) (PID2020-115444GB-I00, /AEI/10.13039/501100011033) to P.R.N; grants from the Ministerio de Ciencia e Innovación (MICINN) Agencia Estatal de Investigación (AEI) (PID2019-108391RB-100), and Comunidad de Madrid (Y2018/BIO-5207, S2018/NMT-4389 and REACT-EU program PR38-21-28 ANTICIPA-CM) to F.M.; Medical Research Council (MR/M020606/1) and Science and Technology Facilities Council (19130001) to C.P.T.; and grants from 2020 Leonardo Grant for Researchers and Cultural Creators (BBVA Foundation), Ayuda de contratación de ayudante de investigación PEJ-2020-AI/BMD-19152 (Comunidad de Madrid), and the Ministerio de Ciencia e Innovación (MICINN) Agencia Estatal de Investigación (AEI) (PID2020-118525RB-I00, AEI/10.13039/501100011033) to J.R.M., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Human T-cell receptor triggering requires inactivation of Lim kinase-1 by Slingshot-1 phosphatase

  • Gómez-Morón, Álvaro
  • Alegre-Gómez, Sergio
  • Ramirez-Muñoz, Rocio
  • Hernaiz-Esteban, Alicia
  • Carrasco-Padilla, Carlos
  • Scagnetti, Camila
  • Aguilar-Sopeña, Óscar
  • García-Gil, Marta
  • Borroto, Aldo
  • Torres-Ruiz, Raul
  • Rodríguez-Perales, Sandra
  • Sánchez-Madrid, Francisco
  • Martín-Cófreces, Noa Beatriz
  • Roda-Navarro, Pedro
Actin dynamics control early T-cell receptor (TCR) signalling during T-cell activation. However, the precise regulation of initial actin rearrangements is not completely understood. Here, we have investigated the regulatory role of the phosphatase Slingshot-1 (SSH1) in this process. Our data show that SSH1 rapidly polarises to nascent cognate synaptic contacts and later relocalises to peripheral F-actin networks organised at the mature immunological synapse. Knockdown of SSH1 expression by CRISPR/Cas9-mediated genome editing or small interfering RNA reveal a regulatory role for SSH1 in CD3ε conformational change, allowing Nck binding and proper downstream signalling and immunological synapse organisation. TCR triggering induces SSH1-mediated activation of actin dynamics through a mechanism mediated by Limk-1 inactivation. These data suggest that during early TCR activation, SSH1 is required for rapid F-actin rearrangements that mediate initial conformational changes of the TCR, integrin organisation and proximal signalling events for proper synapse organisation. Therefore, the SSH1 and Limk-1 axis is a key regulatory element for full T cell activation., Y2018/BIO-5207_SINERGY_CAM/Comunidad de Madrid PID2020-115444GB-I00/Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (Spanish Agencia Estatal de Investigación)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukemia progression

  • Arroyo-Ródenas, Javier
  • Falgàs, Aïda
  • Díez-Alonso, Laura
  • Martínez-Moreno, Alba
  • Roca-Ho, Heleia
  • Gil-Etayo, Francisco J.
  • Pérez-Pons, Alba
  • Aguilar-Sopeña, Óscar
  • Velasco-Sidro, Miriam
  • Gómez-Rosel, Marina
  • Jiménez-Matías, Beatriz
  • Muñoz-Sánchez, Guillermo
  • Pacheco, Yedra
  • Bravo-Martín, Clara
  • Ramírez-Fernández, Ángel
  • Jiménez-Reinoso, Anaïs
  • González-Navarro, Azucena
  • Juan, Manel
  • Orfao, Alberto
  • Blanco, Belén
  • Roda-Navarro, Pedro
  • Bueno, Clara
  • Menéndez, Pablo
  • Álvarez-Vallina, Luis
[Background] CD19-directed cancer immunotherapies, based on engineered T cells bearing chimeric antigen receptors (CARs, CAR-T cells) or the systemic administration of bispecific T cell-engaging (TCE) antibodies, have shown impressive clinical responses in relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL). However, more than half of patients relapse after CAR-T or TCE therapy, with antigen escape or lineage switching accounting for one-third of disease recurrences. To minimize tumor escape, dual-targeting CAR-T cell therapies simultaneously targeting CD19 and CD22 have been developed and validated both preclinically and clinically., [Methods] We have generated the first dual-targeting strategy for B-cell malignancies based on CD22 CAR-T cells secreting an anti-CD19 TCE antibody (CAR-STAb-T) and conducted a comprehensive preclinical characterization comparing its therapeutic potential in B-ALL with that of previously validated dual-targeting CD19/CD22 tandem CAR cells (TanCAR-T cells) and co-administration of two single-targeting CD19 and CD22 CAR-T cells (pooled CAR-T cells)., [Results] We demonstrate that CAR-STAb-T cells efficiently redirect bystander T cells, resulting in higher cytotoxicity of B-ALL cells than dual-targeting CAR-T cells at limiting effector:target ratios. Furthermore, when antigen loss was replicated in a heterogeneous B-ALL cell model, CAR-STAb T cells induced more potent and effective cytotoxic responses than dual-targeting CAR-T cells in both short- and long-term co-culture assays, reducing the risk of CD19-positive leukemia escape. In vivo, CAR-STAb-T cells also controlled leukemia progression more efficiently than dual-targeting CAR-T cells in patient-derived xenograft mouse models under T cell-limiting conditions., [Conclusions] CD22 CAR-T cells secreting CD19 T-cell engagers show an enhanced control of B-ALL progression compared with CD19/CD22 dual CAR-based therapies, supporting their potential for clinical testing., Research in LA-V laboratory is funded by the MCIN/AEI/10.13039/501100011033 (PID2023-148429OB-I00, PID2020-117323RB-I00, PDC2021-121711-I00, CPP2022-009762, CPP2022-009765, CPP2023-010827), the Carlos III (ISCIII) Health Institute with European Regional Development Fund (FEDER) cofinancing (DTS20/00089, PMPTA22/00167); the Asociación Española contra el Cáncer (AECC) (PROYE19084ALVA and PRYGN234844ALVA), the CRIS Cancer Foundation (FCRIS-2021-0090 and FCRIS-2023-0070), the Fundación ‘‘La Caixa’’ (HR21-00761 project IL7R_LungCan), the Fundación para la Investigación Biomédica del Hospital 12 de Octubre (programa Investiga 2022-0082), the Comunidad de Madrid (P2022/BMD-7225 Next Generation CART MAD), and the Fundación FERO (BBASELGAFERO2024.01). Research in PM/CB laboratory is supported by CERCA/Generalitat de Catalunya and Fundació Josep Carreras-Obra Social la Caixa for core support; “the European Research Council grants (ERC-PoC-957466 IT4B-TALL, ERC-PoC-101100665 BiTE-CAR); H2020 (101057250-CANCERNA), the MCIN/AEI/10.13039/501100011033 (PID2022-142966OB-I00 and Feder Funds), MCIN/European Union NextGeneration EU (CPP2021-008508 and CPP2022-009759); the AECC (PRYGN234975MENE and PRYGN211192BUEN), the Fundación Unoentrecienmil (FUECM2024), the ISCIII/FEDER (PI20/00822, PI24/00763) and the ISCIII-RICORS within the Next Generation EU program (plan de Recuperación, Transformación y Resilencia). BB is supported by the ISCIII (PI23/01256), AECC (INNOV211832BLAN) and Comunidad de Madrid (IND2022/BMD-23732). PR-N is funded by MCIN/AEI/10.13039/501100011033 (PID2020-115444GB-I00). AF was supported by a Juan de la Cierva fellowship from the Ministerio de Ciencia, Innovación y Universidades. LDA was supported by a Rio Hortega fellowship from the ISCIII (CM20/00004). OA-S was supported by a PhD fellowship from the Complutense University of Madrid. MG-R is supported by an Industrial PhD fellowship from Comunidad de Madrid (IND2022/BMD-23732)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

3D environment favors persistent changes in cell functions and altered morphology, wrinkling, and biomechanical signature of the nucleus

  • González-Novo, Raquel
  • Zamora-Carreras, H.
  • Armesto, Marina
  • Lope-Planelles, Ana de
  • López-Menéndez, Horacio
  • Roda-Navarro, Pedro
  • Monroy, Francisco
  • Wang, Lin
  • Toseland, Christopher P
  • Redondo-Muñoz, Javier
The interplay between cells and their surrounding microenvironment drives multiple cellular functions, including migration, proliferation, and cell fate transitions. The nucleus is a mechanosensitive organelle; however, the morphological and functional changes of the nucleus induced by a three-dimensional (3D) extracellular environment remain unclear. Here, we report that leukemia Jurkat cells selected after 3D growth conditions retain persistent nuclear changes even after being released from confinement. These altered cells showed aberrant nuclear wrinkling, visualized by the lamin B1 distribution and mediated by disrupted actin dynamics and protein kinase C (PKC)β signaling. Moreover, these cells presented changes in chromatin compaction, transcription, apoptosis, and in vivo dissemination. By combining biomechanical techniques and single-nucleus analysis, we have determined that these cells exhibit a distinct nuclear mechanical behavior and biophysical signature compared with control cells. Together, these findings demonstrate that 3D microenvironments alter leukemia cell biology by promoting persistent changes in chromatin organization, morphology, and mechanical response of the nucleus., We thank the Microscopy Unit of Instituto de Investigación Biosanitaria Gregorio Marañón (IiSGM) for assistance with confocal analyses. We are also grateful to the EM and Animal Facilities of the CIB Margarita Salas platforms for their assistance and support with the EM and in vivo experiments and to the UCM-Genomic CAI Unit for their assistance with microarray experiments. We thank Robert Moorhead and Daniel E. Rollins for assistance and support at Royce@Sheffield. We thank Asociación Española Contra el Cáncer for support and Tobías Álvaro-Thomsen for his assistance. We wish to acknowledge the Henry Royce Institute for Advanced Materials, funded through the Engineering and Physical Sciences Research Council (EP/R00661X/1, EP/S019367/1, EP/P02470X/1, and EP/P025285/1). This research was supported by an FPI Scholarship 2018 (Ministerio de Ciencia e Innovación [MICINN], Agencia Estatal de Investigación [AEI], and Fondo Europeo de Desarrollo Regional [FEDER]) to R.G.-N.; grants from Comunidad de Madrid (Y2018/BIO-5207) and the MICINN AEI (PID2020-115444GB-I00 and AEI/10.13039/501100011033) to P.R.-N.; grants from the MICINN AEI (PID2019-108391RB-100) and Comunidad de Madrid (Y2018/BIO-5207, S2018/NMT-4389, and REACT-EU program PR38-21-28 ANTICIPA-CM) to F.M.; a Biotechnology and Biological Sciences Research Council award (BB/X008460/1), the Medical Research Council (MR/M020606/1), and the Science and Technology Facilities Council (19130001) to C.P.T.; and grants from the 2020 Leonardo Grant for Researchers and Cultural Creators (BBVA Foundation), Ayuda de contratación de ayudante de investigación PEJ-2020-AI/BMD-19152 (Comunidad de Madrid), and the MICINN AEI (PID2020-118525RB-I00, AEI/10.13039/501100011033, and PID2023-150232OB-I00) to J.R.M., Peer reviewed
Docta Complutense
Publication Capítulo o parte de un libro (BookPart)

T cell activation and effector function in the human Jurkat T cell model.

  • Carrasco Padilla, C
  • Aguilar Sopeña, O
  • Gómez Morón, Alvaro
  • Alegre Gómez, Sergio
  • Sánchez Madrid, Francisco
  • Martín Cófreces, Noa Beatriz
  • Roda Navarro, Pedro
In order to understand T cell function, it is necessary to completely decipher the molecular dynamics underlying T cell activation and effector function. In vitro easy-to-handle cellular models are valuable tools to study intracellular molecular mechanisms in live cells. The CD4 T cell line Jurkat (JK) has been widely employed to investigate intracellular signaling leading to T cell activation in response to T cell receptor (TCR) triggering. Here, we describe diverse, complementary protocols to evaluate the TCR- and costimulation-mediated T cell activation, as well as the immunological synapse assembly and cytokine production occurring as a consequence of successful early activation events. This in vitro model is extremely useful to address molecular mechanisms operating during T cell activation and effector function acting in diverse pathophysiological scenarios.